Form 4 Tracker
BeOne Medicines Ltd.
ONC

58 insider filings · Latest: Oct 13, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 2, 2025Sep 2 8:26 PMTITUS BENJAMIN BALL
Proposed Sale
122$326.76$39.9K—

View →

Aug 13, 2025Aug 13 8:30 PMXIAOBIN WU
Proposed Sale
89,794$288.10$25.9M—

View →

Aug 13, 2025Aug 13 8:28 PMCHAN LEE
Proposed Sale
10,338$288.10$3.0M—

View →

Aug 1, 2025Aug 1 8:21 PMAARON ROSENBERG
Proposed Sale
1,190$290.47$345.7K—

View →

Jul 30, 2025Jul 30 8:07 PMCHAN LEE
Proposed Sale
920$304.60$280.2K—

View →

Jul 18, 2025Jul 18 8:46 PMWANG HOLDINGS LLC
Proposed Sale
5,000$290.35$1.5M—

View →

Jul 9, 2025Jul 9 8:15 PMJOHN V OYLER
Proposed Sale
27,802$244.47$6.8M—

View →

Jul 8, 2025Jul 8 8:21 PMPAN-OYLER FOUNDATION
Proposed Sale
1,661$240.99$400.3K—

View →

Jun 24, 2025Jun 24 8:25 PMXIAODONG WANG
Proposed Sale
2,007$257.51$516.8K—

View →

Jun 23, 2025Jun 23 8:09 PMLAI WANG
Proposed Sale
1,028$260.00$267.3K—

View →

Jun 23, 2025Jun 23 8:08 PMXIAOBIN WU
Proposed Sale
1,363$260.00$354.4K—

View →

Jun 23, 2025Jun 23 8:08 PMJOHN OYLER
Proposed Sale
3,174$261.61$830.4K—

View →

Jun 17, 2025Jun 17 8:20 PMJOHN OYLER
Proposed Sale
1,460$256.49$374.5K—

View →

Jun 17, 2025Jun 17 8:19 PMLAI WANG
Proposed Sale
470$251.37$118.1K—

View →

Jun 17, 2025Jun 17 8:18 PMXIAOBIN WU
Proposed Sale
630$250.87$158.0K—

View →

Jun 16, 2025Jun 16 8:16 PMXIAOBIN WU
Proposed Sale
1,543$266.52$411.2K—

View →

Jun 16, 2025Jun 16 8:15 PMCHAN LEE
Proposed Sale
422$266.50$112.5K—

View →

Jun 16, 2025Jun 16 8:14 PMJOHN OYLER
Proposed Sale
3,680$266.05$979.0K—

View →

Jun 16, 2025Jun 16 8:03 PMLAI WANG
Proposed Sale
1,177$266.40$313.6K—

View →

Jun 11, 2025Jun 11 8:15 PMTITUS BENJAMIN BALL
Proposed Sale
134$258.36$34.6K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Oct 13, 2026Oct 15 9:08 PMXiaodong WangDirector, Other
Option Exercise
403,351—403,364(D)

View →

Sep 28, 2026Sep 30 9:11 PMXiaodong WangDirector, Other
Option Exercise
403,364—806,715(D)

View →

Sep 8, 2026Sep 10 8:49 PMXiaodong WangDirector, Other
Option Exercise
403,351—1,210,079(D)

View →

Aug 11, 2026Aug 14 12:54 AMChan Henry LeeSVP, General Counsel
Option Exercise
34,658—88,582(D)

View →

Jul 22, 2026Jul 24 8:51 PMChan Henry LeeSVP, General Counsel
Option Exercise
21,697—98,930(D)

View →

Jul 20, 2026Jul 22 9:03 PMJohn OylerDirector, Chief Executive Officer
Option Exercise
441,870—0(D)

View →

Jul 17, 2026Jul 17 9:36 PMJohn OylerDirector, Chief Executive Officer
Option Exercise
840,164—441,870(D)

View →

Jul 16, 2026Jul 17 9:31 PMJohn OylerDirector, Chief Executive Officer
Option Exercise
2,165,761—1,282,034(D)

View →

Jul 15, 2026Jul 17 9:31 PMJohn OylerDirector, Chief Executive Officer
Option Exercise
1,515,241—1,254,513(D)

View →

Jul 14, 2026Jul 15 1:26 AMJohn OylerDirector, Chief Executive Officer
Option Exercise
1,736,800—462,866(D)

View →

Jul 13, 2026Jul 15 1:25 AMJohn OylerDirector, Chief Executive Officer
Option Exercise
630,760—1,264,666(D)

View →

Jul 10, 2026Jul 15 1:25 AMJohn OylerDirector, Chief Executive Officer
Option Exercise
152,074—1,895,426(D)

View →

Jul 8, 2026Jul 10 8:44 PMChan Henry LeeSVP, General Counsel
Option Exercise
8,632—105,300(D)

View →

Jun 11, 2026Jun 15 9:55 PMLai WangPresident, Global Head of R&D
Grant/Award
229,775—229,775(D)

View →

Jun 11, 2026Jun 15 9:55 PMAaron RosenbergChief Financial Officer
Grant/Award
137,865—137,865(D)

View →

Jun 11, 2026Jun 15 9:55 PMXiaobin WuPresident and COO
Grant/Award
229,775—229,775(D)

View →

Jun 11, 2026Jun 15 9:55 PMChan Henry LeeSVP, General Counsel
Grant/Award
87,308—87,308(D)

View →

Jun 11, 2026Jun 15 9:55 PMJohn OylerDirector, Chief Executive Officer
Grant/Award
344,669—344,669(D)

View →

Jun 11, 2026Jun 15 9:54 PMXiaodong WangDirector, Other
Grant/Award
193,492—193,492(D)

View →

May 13, 2026May 15 8:39 PMChan Henry LeeSVP, General Counsel
Option Exercise
4,316—107,848(D)

View →

Page 1 of 2

Next →